175 related articles for article (PubMed ID: 28595197)
1. High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury.
Shan J; Lei H; Shi W; Sun X; Tang Y; Ren C
Dig Dis; 2018; 36(1):66-71. PubMed ID: 28595197
[TBL] [Abstract][Full Text] [Related]
2. [Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication].
Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Moreno L; MartÃn de Argila C
Gastroenterol Hepatol; 2001 Feb; 24(2):56-62. PubMed ID: 11247290
[TBL] [Abstract][Full Text] [Related]
3. Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring serum pepsinogen in H. pylori-infected subjects.
Iijima K; Koike T; Ara N; Nakagawa K; Kondo Y; Uno K; Hatta W; Asano N; Imatani A; Shimosegawa T
J Gastroenterol; 2015 Mar; 50(3):305-12. PubMed ID: 24952898
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of gastric acid secretion in patients with chronic renal failure: influence of Helicobacter pylori infection.
Watanabe H; Hiraishi H; Ishida M; Kazama JJ; Terano A
J Intern Med; 2003 Nov; 254(5):439-46. PubMed ID: 14535965
[TBL] [Abstract][Full Text] [Related]
5. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
Gong Y; Wei W; Yuan Y
Diagn Microbiol Infect Dis; 2014 Dec; 80(4):316-20. PubMed ID: 25284372
[TBL] [Abstract][Full Text] [Related]
6. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
Iijima K; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(25):7709-17. PubMed ID: 26167071
[TBL] [Abstract][Full Text] [Related]
7. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
[TBL] [Abstract][Full Text] [Related]
8. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics.
Lin JT; Wang JT; Wu MS; Huang SC; Wang TH
Hepatogastroenterology; 1993 Dec; 40(6):600-3. PubMed ID: 8119648
[TBL] [Abstract][Full Text] [Related]
10. Serum pepsinogen levels indicate the requirement of upper gastrointestinal endoscopy among Group A subjects of ABC classification: a multicenter study.
Chinda D; Shimoyama T; Mikami T; Arai T; Chiba D; Sasaki Y; Komai K; Sawada Y; Saito Y; Chiba H; Fukuda S;
J Gastroenterol; 2018 Aug; 53(8):924-931. PubMed ID: 29353347
[TBL] [Abstract][Full Text] [Related]
11. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
12. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China.
Sun LP; Gong YH; Wang L; Yuan Y
World J Gastroenterol; 2007 Dec; 13(48):6562-7. PubMed ID: 18161928
[TBL] [Abstract][Full Text] [Related]
13. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
Hamashima C; Sasazuki S; Inoue M; Tsugane S;
BMC Cancer; 2017 Mar; 17(1):183. PubMed ID: 28279154
[TBL] [Abstract][Full Text] [Related]
14. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
Feldman M; Cryer B; Mallat D; Go MF
Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
[TBL] [Abstract][Full Text] [Related]
15. The new modified ABCD method for gastric neoplasm screening.
Park CH; Kim EH; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
Gastric Cancer; 2016 Jan; 19(1):128-35. PubMed ID: 25663259
[TBL] [Abstract][Full Text] [Related]
16. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.
Eun Bae S; Hoon Lee J; Soo Park Y; Ok Kim S; Young Choi J; Yong Ahn J; Hoon Kim D; Don Choi K; June Song H; Hyug Lee G; Choe J; Jin Jang S; Jung HY
Scand J Gastroenterol; 2016; 51(2):137-44. PubMed ID: 26513345
[TBL] [Abstract][Full Text] [Related]
17. Influences of Helicobacter pylori on serum pepsinogen concentrations in dialysis patients.
Tamura H; Tokushima H; Murakawa M; Matsumura O; Itoyama S; Mitarai T; Isoda K
Nephrol Dial Transplant; 1999 Jan; 14(1):113-7. PubMed ID: 10052488
[TBL] [Abstract][Full Text] [Related]
18. Changes with aging in gastric biomarkers levels and in biochemical factors associated with
Shan JH; Bai XJ; Han LL; Yuan Y; Sun XF
World J Gastroenterol; 2017 Aug; 23(32):5945-5953. PubMed ID: 28932086
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
20. Cutoff serum pepsinogen values for predicting gastric acid secretion status.
Iijima K; Koike T; Abe Y; Shimosegawa T
Tohoku J Exp Med; 2014 Apr; 232(4):293-300. PubMed ID: 24717778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
